[1] |
LI Min, LI Chunlei, SUN Cuicui, YU Wenwen, SUN Qing, QI Yingmei, LIU Anchang.
One Case of Acute Generalized Exanthematous Pustulosis Caused by Abrocitinib Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 823-825.
|
[2] |
WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian.
One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688.
|
[3] |
LIU Qian, LI Bo, SHU Xinyang.
Lanqin oral liquid combined with antibacterial drugs for the treatment of acute tonsillitis: a systematic review and Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 916-920.
|
[4] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[5] |
GUO Yijun, CHEN Xia, MENG Ping.
Adverse drug reaction reports in 141 cases of orally administered targeted anti-tumor drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1137-1142.
|
[6] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[7] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[8] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[9] |
JIANG Zhuoxi, LIN Zhijian, ZHANG Bing, WANG Yu, XU Huizhe, MAO Qiuyue.
Effect of smilax glabra extract on intestinal barriers in mice with antibiotic-associated diarrhea: an experimental study
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 862-867.
|
[10] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[11] |
ZHU Xuting, REN Jia, HANG Yongfu.
Three cases of antibiotic encephalopathy caused by ceftriaxone sodium injection in dialysis patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 336-338.
|
[12] |
LI Jiayi, GE Feilin, CAO Junling, ZHOU Xiaochun, GAO Yunjuan, MU Guangdi, ZHAO Xu, CAO Boya, GUO Yuming.
Clinical Characteristics and Rationality of Drug Usage in Antibiotic Agents Related Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1020-1024.
|
[13] |
WEI Yuanyuan, LI Fang, TAO Xiaomei, GU Hongyan.
Prevention of Adverse Reactions of Antibiotics in a Respiratory Department
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1083-1086.
|
[14] |
GONG Yu, ZHENG Zhixin, JING Tianchuang, SU Dan.
Analysis of One Case of Severe Pneumonia in The Elderly Complicated with Drug Fever Induced by Vancomycin
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 845-847.
|
[15] |
LYU Tianyi, KUANG Li, CHEN Mingying.
Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
|